Skip to main content

Univasc Side Effects

Generic name: moexipril

Medically reviewed by Last updated on Jan 4, 2024.

Note: This document contains side effect information about moexipril. Some dosage forms listed on this page may not apply to the brand name Univasc.

Applies to moexipril: oral tablet.


Oral route (Tablet)

Discontinue moexipril hydrochloride as soon as possible once pregnancy is detected since drugs that act directly on the renin-angiotensin system can case injury and death to the developing fetus.

Serious side effects of Univasc

Along with its needed effects, moexipril (the active ingredient contained in Univasc) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking moexipril:

Less common

Other side effects of Univasc

Some side effects of moexipril may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to moexipril: oral tablet.


The most commonly reported adverse effects considered to be related to use of this drug were headache, cough, dizziness, fatigue, flushing, and rash.[Ref]


Common (1% to 10%): Fatigue, flu syndrome, pain, peripheral edema, chest pain

Uncommon (0.1% to 1%): Fever

Rare (less than 0.1%): Malaise[Ref]


Common (1% to 10%): Cough, pharyngitis, upper respiratory tract infection, rhinitis, sinusitis

Rare (less than 0.1%): Bronchospasm, dyspnea

Frequency not reported: Eosinophilic pneumonitis[Ref]


Common (1% to 10%): Diarrhea, dyspepsia, nausea

Uncommon (0.1% to 1%): Abdominal pain, constipation, vomiting

Rare (0.01% to 0.1%): Dry mouth

Very rare (less than 0.01%): Pancreatitis

Frequency not reported: Intestinal angioedema[Ref]

Nervous system

Common (1% to 10%): Headache, dizziness

Uncommon (0.1% to 1%): Cerebrovascular accident, transient ischemic attack, syncope

Rare (less than 0.1%): Numbness, paresthesia, balance disturbance, drowsiness, tingling sensations, alteration or transient loss of taste, tinnitus[Ref]


Common (1% to 10%): Serum creatinine increased, BUN increased

Rare (less than 0.1%): Acute renal failure, renal insufficiency[Ref]


Common (1% to 10%): Rash

Uncommon (0.1% to 1%): Stevens-Johnson syndrome, toxic epidermal necrolysis, pruritus, urticaria, erythema multiforme, psoriasis-like efflorescence, pemphigus, alopecia

Rare (less than 0.1%): Angioedema

Frequency not reported: Sweating, photosensitivity[Ref]


Common (1% to 10%): Flushing

Uncommon (0.1% to 1%): Myocardial infarction, angina pectoris, rhythm disorder, tachycardia, palpitation, hypotension

Frequency not reported: Symptomatic hypotension, postural hypotension[Ref]


Common (1% to 10%): Myalgia

Uncommon (0.1% to 1%): Arthralgia[Ref]


Common (1% to 10%): Urinary frequency

Rare (less than 0.1%): Impotence

Frequency not reported: Oliguria[Ref]


Uncommon (0.1% to 1%): Appetite loss, uric acid elevated

Rare (less than 0.1%): Hyperkalemia

Frequency not reported: Hyponatremia[Ref]


Rare (0.01% to 0.1%): Anemia, neutropenia, eosinophilia, thrombocytopenia

Very rare (less than 0.01%): Pancytopenia, agranulocytosis, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, hemoglobin decreased, hematocrit decreased, platelets decreased, white cell count decreased[Ref]


Rare (less than 0.1%): Confusion, depression, sleep disturbances

Frequency not reported: Nervousness, mood changes, anxiety[Ref]


Rare (less than 0.1%): Vision blurred[Ref]


Very rare (less than 0.01%): Hepatitis, liver enzymes elevated, serum bilirubin elevated[Ref]


1. Product Information. Univasc (moexipril). Schwarz Pharma. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.